Trials / Unknown
UnknownNCT01074567
DMSO Efficacy in IC/PBS Patients During and After Treatment
Efficacy of DMSO Cocktail Treatment in Interstitial Cystitis Patients During and After Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Assaf-Harofeh Medical Center · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the efficacy of dimethylsulphoxide (DMSO) cocktail in patients with interstitial cystitis during the treatment period (12 weeks) and after it (at 6 weeks, 3, 6 and 12 month).
Detailed description
The modern treatment of IC is a multi-modal treatment which includes behavioural treatment, physiotherapy of the pelvic floor musculature, oral medication (e.g. Amitryptiline) and intra-vesical instillation (e.g. DMSO, steroids, heparin). These treatments were found to be effective in a number of studies and are approved by the FDA. However, the optimal duration of intra-vesical instilation is not known. All patients with IC (according to the international continence society criteria) will receive 12 weekly intra-vesical instillation of DMSO. All patients will fill an O'leary-Sant questionaire and a urination diary before treatment, after 3, 6, 9 and 12 treatments and at 6 weeks, 3, 6 and 12 month after the end to the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DMSO cocktail | intra-vesical: DMSO 50% in 50 cc water for injection 10 cc heparin 5000 IU hydrocortisone 100 mg bupivacaine 0.125% |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-12-01
- Completion
- 2012-12-01
- First posted
- 2010-02-24
- Last updated
- 2011-04-05
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01074567. Inclusion in this directory is not an endorsement.